Literature DB >> 29926010

Pulmonary Tumor Thrombotic Microangiopathy Induced by Prostate Cancer.

Satoshi Katayama1, Tadasu Takenaka, Aya Nakamura, Sinichi Sako, Akihiro Bessho, Nobuya Ohara.   

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal, malignancy-related respiratory complication; we herein report a PTTM case induced by metastatic prostate cancer. An 81-year-old Japanese man developed dyspnea. High-resolution computed tomography (HRCT) revealed ground-glass opacities spread across bilateral lung fields. Pulmonary microvascular aspiration cytology detected prostate cancer cells. As PTTM was highly suspected, docetaxel chemotherapy was performed immediately. His respiratory condition and HRCT findings improved temporarily, but he died approx. 6 weeks after admission. Autopsy showed fibrocellular intimal proliferation of small pulmonary arterioles, which confirmed the diagnosis of PTTM induced by prostate cancer. As in the present case, it is often difficult to confirm the presence of not only tumor embolization but also fibrocellular intimal proliferation before the patient's death.

Entities:  

Keywords:  autopsy; dyspnea; metastatic lung cancer; prostate neoplasm; thrombotic microangiopathy

Mesh:

Year:  2018        PMID: 29926010     DOI: 10.18926/AMO/56078

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  2 in total

1.  An autopsy case of massive pulmonary tumor embolism due to undiagnosed prostatic adenocarcinoma.

Authors:  Aleksandra Lovrenski; Željka Vrekić; Dušan Škrbić; Bojana Andrejić Višnjić; Milena Vasilijević; Lidija Vrtunski More
Journal:  Forensic Sci Med Pathol       Date:  2019-11-05       Impact factor: 2.007

Review 2.  A Long-term Survival Case of Pulmonary Tumor Thrombotic Microangiopathy due to Gastric Cancer Confirmed by the Early Diagnosis based on a Transbronchial Lung Biopsy.

Authors:  Takeshi Imakura; Toshifumi Tezuka; Mami Inayama; Ryota Miyamoto; Akane Abe; Kanako Otsuka; Seiji Yoshida; Eiji Kudo; Takashi Haku
Journal:  Intern Med       Date:  2020-07-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.